• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$50.87 $0.37 (0.73%)

REAL-TIME: Last trade at

Salix Pharmaceuticals, Ltd.

NASDAQ:SLXP

Jump to this page for:

Related Resources

Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2012

5/18/2012 by PharmiWeb.com - UK

Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2012

5/18/2012 by Business Wire

Piper Jaffray's healthcare equipment and biotech analysts hold a conference call

5/16/2012 by Theflyonthewall.com

Salix management to meet with JMP Securities

5/14/2012 by Theflyonthewall.com

Jefferies Boosts Price Target on Salix Pharmaceuticals (SLXP)

5/8/2012 by StreetInsider.com

Salix Pharmaceuticals Reports 1Q2012 Results

5/8/2012 by PharmiWeb.com - UK

Salix sees FY12 adjusted EPS $2.59, consensus $2.54

5/7/2012 by Theflyonthewall.com

Salix reports Q1 adjusted EPS 67c, consensus 57c

5/7/2012 by Theflyonthewall.com

Drugmaker Salix's Q1 Earnings Expected To Soar 68%

5/4/2012 by Investor's Business Daily

Biotechnology And Drugs Stocks To Watch Next Week

5/1/2012 by Seeking Alpha

Salix Pharmaceuticals to Present at Three Investment Conferences in May

5/1/2012 by PharmiWeb.com - UK

Salix Pharmaceuticals to Present at Three Investment Conferences in May

5/1/2012 by Business Wire

Salix Pharmaceuticals Announces Extension of Crofelemer NDA Priority Review

5/1/2012 by PharmiWeb.com - UK

FDA Extends PDUFA Date for Priority Review of NDA for Salix Pharma's (SLXP) Crofelemer Tablets

4/30/2012 by StreetInsider.com

Salix says new PDUFA date for Crofelemer set for September 5

4/30/2012 by Theflyonthewall.com

Salix Pharmaceuticals Announces Extension of Crofelemer NDA Priority Review

4/30/2012 by Business Wire

Salix and Progenics' Relistor sNDA goal date extended by FDA to July 27

4/25/2012 by Theflyonthewall.com

Salix and Progenics Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012

4/25/2012 by Business Wire

The Zacks Analyst Blog Highlights: US Airways Group, United Continental Holdings, Delta Airlines, Salix Pharmaceuticals and Progenics Pharmaceuticals

4/24/2012 by PR Newswire

The Zacks Analyst Blog Highlights: US Airways Group, United Continental Holdings, Delta Airlines, Salix Pharmaceuticals and Progenics Pharmaceuticals - Press Releases

4/24/2012 by Zacks Investment Research

Top 10 Stocks With Increasing Sales And Profit Margins

4/24/2012 by Seeking Alpha

Salix Pharmaceuticals Announces 1Q2012 Financial Results Conference Call and Webcast

4/23/2012 by PharmiWeb.com - UK

Salix Pharmaceuticals Announces 1Q2012 Financial Results Conference Call and Webcast

4/23/2012 by Business Wire

Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Suggests Buying Into Weakness

4/11/2012 by StreetInsider.com

Wells Fargo Maintains an 'Outperform' on Salix Pharmaceuticals (SLXP); Buy on Weakness

4/10/2012 by StreetInsider.com

Indexes' Losses Pick Up in Afternoon; Apple Off Highs

4/10/2012 by Investor's Business Daily

Salix downgraded to Hold from Buy at Auriga

4/10/2012 by Theflyonthewall.com

Piper Jaffray's biotech and specialty pharma analysts hold a conference call

4/5/2012 by Theflyonthewall.com

Buckingham Research Downgrades Salix Pharmaceuticals (SLXP) to Neutral

3/27/2012 by StreetInsider.com

Salix downgraded to Neutral from Buy at Buckingham

3/27/2012 by Theflyonthewall.com

15 Biotech Companies Waiting For FDA Approval (PFE, BMY, GILD, VRTX, SLXP)

3/21/2012 by Investopedia

Salix Pharmaceuticals Closes Sale of Convertible Notes

3/16/2012 by Genetic Engineering News

Salix Pharma (SLXP) Closes $690M Convertible Notes Offering

3/16/2012 by StreetInsider.com

Salix Pharmaceuticals Closes Sale of Convertible Notes

3/16/2012 by Business Wire

Salix Pharmaceuticals Prices Convertible Notes Offering

3/13/2012 by Genetic Engineering News

Salix Pharmaceuticals Prices Convertible Notes Offering

3/13/2012 by Business Wire

Salix Pharmaceuticals (SLXP) Top Offer $500M In Conv. Notes

3/12/2012 by StreetInsider.com

Salix Pharmaceuticals Announces Proposed Convertible Notes Offering

3/12/2012 by StockWatch

Salix files $500M convertible senior notes offering

3/12/2012 by Theflyonthewall.com

Salix Pharmaceuticals Announces Proposed Convertible Notes Offering

3/12/2012 by Business Wire
See More Articles...